FinanceBiogen (BIIB) Gets EU Approval for Rare Disease Drug QalsodyMay 31, 202487Biogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody for treating patients with amyotrophic lateral sclerosis...
